FDA Drug Application (020405) for LANOXIN by CONCORDIA PHARMS INC

Back to FDA Applications sponsored by CONCORDIA PHARMS INC

Application Number020405
Product Number001
FormTABLET;ORAL
Dosage0.0625MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLANOXIN
Active IngredientDIGOXIN



Back to FDA Applications sponsored by CONCORDIA PHARMS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.